SciClone Pharmaceuticals
SciClone profit up 4.3% to RMB622.7m in H1 2021
SciClone profit up 4.3% to RMB622.7m in H1 2021
Its revenue rose 14.7% to RMB1.3b in the same period.
Most Read
1. Global endoscopic closure devices market to grow by $825.7m by 2029 2. NHG names new Chairman, Medical Board of Khoo Tech Puat Hospital 3. Qatar develops advanced occupational and environmental medicine programme 4. New Communicable Diseases Agency to be set up in first half of 2025 5. AI-driven adaptive cardiac devices to improve heart disease treatmentResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
He discussed the pressing challenges and transformative solutions shaping the future of healthcare in the Asia Pacific.
